Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens
- PMID: 4345967
Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens
Similar articles
-
Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration.J Natl Cancer Inst. 1972 Feb;48(2):541-9. J Natl Cancer Inst. 1972. PMID: 4119886 No abstract available.
-
Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues.Cancer Res. 1973 Dec;33(12):3165-71. Cancer Res. 1973. PMID: 4357351 No abstract available.
-
The macrophage aggregation assay for cell-mediated immunity in man. Studies of patients with Hodgkin's disease and sarcoidosis.J Lab Clin Med. 1973 Oct;82(4):682-91. J Lab Clin Med. 1973. PMID: 4585463 No abstract available.
-
In vitro models of cellular hypersensitivity.Adv Biol Skin. 1971;11:345-55. Adv Biol Skin. 1971. PMID: 4950203 Review. No abstract available.
-
[Recent progress in immunology].Rinsho Byori. 1971 Feb;19(2):119-25. Rinsho Byori. 1971. PMID: 4106973 Review. Japanese. No abstract available.
Cited by
-
Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins.Br J Cancer. 1979 Dec;40(6):831-8. doi: 10.1038/bjc.1979.273. Br J Cancer. 1979. PMID: 93484 Free PMC article.
-
Immune response to chemically induced tumours: correlation of responding cell class with in vivo inhibition of tumour growth.Br J Cancer. 1981 Apr;43(4):505-16. doi: 10.1038/bjc.1981.73. Br J Cancer. 1981. PMID: 6972224 Free PMC article.
-
Immunogenicity of cellular and acellular antigen preparations from a methylcholanthrene-induced mouse sarcoma.J Cancer Res Clin Oncol. 1982;104(3):237-47. doi: 10.1007/BF00406244. J Cancer Res Clin Oncol. 1982. PMID: 6761343 Free PMC article.
-
Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations.Cancer Immunol Immunother. 1991;34(2):103-10. doi: 10.1007/BF01741343. Cancer Immunol Immunother. 1991. PMID: 1760813 Free PMC article.
-
Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.Cancer Immunol Immunother. 1990;31(5):297-304. doi: 10.1007/BF01740938. Cancer Immunol Immunother. 1990. PMID: 2376047 Free PMC article.